Revision history of "BRIEF-AstraZeneca Says PT027 PhIII Asthma Trials Met Primary Endpoints"

Jump to: navigation, search

Diff selection: Mark the radio boxes of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

  • curprev 23:05, 18 November 2021‎ TamieBelz13 talk contribs‎ 1,039 bytes +1,039‎ Created page with "<br>Sept 9 (Reuters) - AstraZeneca PLC:<br> <br>* ASTRAZENECA PLC - PT027 PHIII ASTHMA TRIALS MET PRIMARY ENDPOINTS<br> <br>* ASTRAZENECA - FIXED-DOSE COMBINATION OF ALBUTEROL..."
Retrieved from "http://wiki.jenny3dprint.com/index.php?title=BRIEF-AstraZeneca_Says_PT027_PhIII_Asthma_Trials_Met_Primary_Endpoints"